tachycardia tirzepatide Side Effects: Common, Severe, Long Term Tirzepatide and Cardiovascular Outcomes in

It is important to contextualise these results carefully: Phase 2 trials involve relatively small, controlled populations and are not sufficient on their own to establish a medicine's full safety profile or its suitability for broad clinical use

But one simple question remains: Does metformin actually work and does it cause weight loss

Mounjaro (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities as an adjunct to reduced-calorie diet and increased physical activity

108 The proposed mechanism for its metabolism is the cleavage of the active side chain of MEP by blood esterase(s)

The drug has been approved globally for the management of type 2 diabetes mellitus in adult patients in the U.S